nach oben

Journal of Gastrointestinal Cancer

Erschienen in:

03.01.2017 | Case Report

Brain Metastasis as Initial Presentation of Rectal Adenocarcinoma: an Unusual Case in a Very Young Patient

verfasst von: Jyotsana Sinha, Rong Zhang, Vinit V. Patil, Miguel A Guzman, Nishant Poddar

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Excerpt

Colorectal cancer [CRC] is the third most commonly diagnosed and cause of cancer related deaths in both genders in the USA [1].The incidence varies by age and is most common among adults >50 years [2]. Brain metastasis is rare with an incidence of 1–4% [3].Most brain metastases develop during the course of disease while the presence at initial presentation is rare. RAS mutation is associated with metastasis in CRC [4]. We present a 36-year-old male with brain metastasis as the initial presentation of a RAS unmutated rectal adenocarcinoma with microsatellite instability [MSI] and multiple synchronous metastases. …

Jung M, Ahn JB, Chang JH, et al. Brain metastases from colorectal carcinoma: prognostic factors and outcome. J Neuro-Oncol. 2011;101:49–55.CrossRef

American Cancer Society, Colorectal Cancer Facts & Figures [Internet], 2014 http://www.cancer.org/acs/groups/content/documents/document/acspc-042280.pdf

Damiens K, Ayoub JP, Lemieux B, et al. Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution. Curr Oncol. 2012;19:254–8.CrossRefPubMedPubMedCentral

Yaeger R, Cowell E, Chou JF, et al. RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer. Cancer. 2015;121:1195–203.CrossRefPubMed

Edwards BK, Noone AM, Henley SJ, et al. Annual report to the nation on the status of cancer 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast or prostate cancer. Cancer. 2014;120(9):1290–314.CrossRefPubMed

Onodera H, Nagayama S, Tachibana T, et al. Brain metastasis from colorectal cancer. Int J Colorectal Disease. 2005;20:57–61.CrossRef

Wroński M, Arbit E. Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer. 1999;85(8):1677–85.CrossRefPubMed

Zang Y-W, Gu X-D, Xiang J-B, et al. Brain metastases from colorectal cancer: microenvironment and molecular mechanisms. Int J Mol Sciences. 2012;13:15784–800.CrossRef

Houlston RS. What we could do now: molecular pathology of colorectal cancer. Mol Pathol. 2001;54:206–14.CrossRefPubMedPubMedCentral

Titel: Brain Metastasis as Initial Presentation of Rectal Adenocarcinoma: an Unusual Case in a Very Young Patient
verfasst von: Jyotsana Sinha
Rong Zhang
Vinit V. Patil
Miguel A Guzman
Nishant Poddar
Publikationsdatum: 03.01.2017
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Cancer / Ausgabe 3/2018
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-016-9911-8

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Brain Metastasis as Initial Presentation of Rectal Adenocarcinoma: an Unusual Case in a Very Young Patient

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

A Rare Entity of Gastrointestinal Stromal Tumour Arising from a Meckel’s Diverticulum: a Case Report

Characteristics and Impacts of Venous Thromboembolism in Patients with Hepatocellular Carcinoma

Gastric Metastasis from Hepatocellular Carcinoma: A Rare Manifestation

Portocaval Paraganglioma : First Case Report and Review of Literature

A Case Report—Stevens-Johnson Syndrome as an Adverse Effect of Capecitabine

Predictive Power of the NSQIP Risk Calculator for Early Post-Operative Outcomes After Whipple: Experience from a Regional Center in Northern Ontario

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie